Predictive value of HRD testing on the response to PARP inhibitors in ovarian cancer preclinical models-MedSci.cn

Predictive value of HRD testing on the response to PARP inhibitors in ovarian cancer preclinical models

Dellavedova, G; Decio, A; Formenti, L; Porcu, L; Ghilardi, C; Giavazzi, R; Bani, MR